Novocure Ltd (NVCR)

Nov 26, 2024

NVCR (NovoCure) Shares Outstanding (EOP) : 108.1 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 25, 2024

Novocure's SWOT analysis: FDA approval boosts cancer tech stock prospects - Investing.com

Nov 25, 2024

Nov 25, 2024

NovoCure (NASDAQ:NVCR) Receives Buy Rating from HC Wainwright - Defense World

Nov 25, 2024

Nov 24, 2024

NVCR (NovoCure) Growth Rank : 8 (As of Nov. 24, 2024) - GuruFocus.com

Nov 24, 2024

Nov 23, 2024

Connor Clark & Lunn Investment Management Ltd. Acquires 59,608 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat

Nov 23, 2024

Nov 22, 2024

FDA approves Novocure's new device for brain cancer treatment By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 21, 2024

Novocure secures FDA approval for add-ons to brain cancer treatment wearable - Yahoo Finance

Nov 21, 2024

Nov 21, 2024

Novocure’s HFE Transducer Arrays OK’ed with Optune Gio for Glioblastoma - MPO-mag

Nov 21, 2024

Nov 21, 2024

FDA approves Novocure's new device for brain cancer treatment - Investing.com

Nov 21, 2024

Nov 21, 2024

Novocure to Present Breakthrough TTFields Brain Cancer Treatment Data at SNO Meeting | NVCR Stock News - StockTitan

Nov 21, 2024

Nov 21, 2024

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma - Yahoo Finance

Nov 21, 2024

Nov 18, 2024

Can Novocure's PANOVA-3 Trial Of TTFields Therapy Electrify The Stock? - RTTNews

Nov 18, 2024

Nov 16, 2024

NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 16, 2024

Nov 14, 2024

NovoCure (NVCR) Shares Cross Below 200 DMA - Nasdaq

Nov 14, 2024

Nov 14, 2024

NovoCure Ltd (NVCR) Trading Down 2.79% on Nov 14 - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Baillie Gifford & Co. Sells 28,207 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat

Nov 13, 2024

Nov 11, 2024

Analyze NovoCure Ltd (NASDAQ: NVCR) Before Investing. - Stocks Register

Nov 11, 2024

Nov 09, 2024

Nordwand Advisors LLC Buys 1,514,824 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat

Nov 09, 2024

Nov 08, 2024

NovoCure Ltd (NVCR) Shares Up 3.63% on Nov 8 - GuruFocus.com

Nov 08, 2024

Nov 05, 2024

Novocure's oncology president sells $9,530 in shares - Investing.com India

Nov 05, 2024

Nov 04, 2024

Novocure's COO Mukund sells shares worth $2,540 By Investing.com - Investing.com Canada

Nov 04, 2024

Nov 04, 2024

Novocure's COO Mukund sells shares worth $2,540 - Investing.com India

Nov 04, 2024

Nov 04, 2024

Michal Nath Puri Sells 810 Shares of NovoCure Limited (NASDAQ:NVCR) Stock - MarketBeat

Nov 04, 2024

Nov 04, 2024

Novocure's oncology president sells $9,530 in shares By Investing.com - Investing.com Australia

Nov 04, 2024

Nov 04, 2024

NovoCure Ltd (NVCR) Shares Up 3.96% on Nov 4 - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

FY2024 EPS Estimates for NovoCure Lifted by HC Wainwright - MarketBeat

Nov 04, 2024

Nov 01, 2024

Analyst Estimates: Here's What Brokers Think Of NovoCure Limited (NASDAQ:NVCR) After Its Third-Quarter Report - Simply Wall St

Nov 01, 2024

Nov 01, 2024

NovoCure Limited (NASDAQ:NVCR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024

Nov 01, 2024

NovoCure shares hold Buy rating, steady price target post-earnings - Investing.com

Nov 01, 2024

Oct 31, 2024

NovoCure shares hold Buy rating, steady price target post-earnings By Investing.com - Investing.com UK

Oct 31, 2024

Oct 31, 2024

NovoCure's (NVCR) Buy Rating Reiterated at HC Wainwright - MarketBeat

Oct 31, 2024

Oct 31, 2024

NovoCure’s Strong Q3 and Leadership Changes in 2024 - Yahoo Finance

Oct 31, 2024

Oct 31, 2024

NovoCure: Q3 Earnings Snapshot - Milford Mirror

Oct 31, 2024

Oct 31, 2024

NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

Oct 31, 2024

Oct 31, 2024

NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance

Oct 31, 2024

Oct 31, 2024

Novocure names Christoph Brackmann as new CFO - Investing.com India

Oct 31, 2024

Oct 31, 2024

Novocure’s Q3 2024 Results Highlight Growth and Innovation - TipRanks

Oct 31, 2024

Oct 30, 2024

NovoCure (NASDAQ:NVCR) Stock Price Down 7.1%Should You Sell? - MarketBeat

Oct 30, 2024

Oct 30, 2024

Novocure Ltd earnings beat by $0.05, revenue topped estimates - Investing.com

Oct 30, 2024

Oct 30, 2024

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Oct 30, 2024

Oct 30, 2024

Novocure Appoints Christoph Brackmann as Chief Financial Officer - Yahoo Finance

Oct 30, 2024

Oct 30, 2024

Novocure Reports Third Quarter 2024 Financial Results - Yahoo Finance

Oct 30, 2024

Oct 28, 2024

Semanteon Capital Management LP Makes New Investment in NovoCure Limited (NASDAQ:NVCR) - MarketBeat

Oct 28, 2024

Oct 23, 2024

NovoCure (NVCR) Set to Announce Quarterly Earnings on Wednesday - MarketBeat

Oct 23, 2024

Oct 22, 2024

Brokerages Set NovoCure Limited (NASDAQ:NVCR) PT at $26.17 - MarketBeat

Oct 22, 2024

Oct 21, 2024

NovoCure Limited (NASDAQ:NVCR) Shares Sold by SG Americas Securities LLC - MarketBeat

Oct 21, 2024

Oct 19, 2024

Novocure shares soar 33% as FDA approves lung cancer treatment - MSN

Oct 19, 2024

Oct 18, 2024

Leerink Partnrs Forecasts Stronger Earnings for NovoCure - MarketBeat

Oct 18, 2024

Oct 17, 2024

NovoCure scoops FDA approval on wearable for metastatic cancer treatment - Medical Device Network

Oct 17, 2024

Oct 17, 2024

Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment - Yahoo Finance

Oct 17, 2024